35351-21-4,MFCD06357123
Catalog No.:AA00C93K

35351-21-4 | 5-Bromo-1-benzofuran-2-carboxamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$99.00   $69.00
- +
5g
98%
in stock  
$321.00   $225.00
- +
10g
98%
in stock  
$583.00   $408.00
- +
25g
98%
in stock  
$1,154.00 $808.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00C93K
Chemical Name:
5-Bromo-1-benzofuran-2-carboxamide
CAS Number:
35351-21-4
Molecular Formula:
C9H6BrNO2
Molecular Weight:
240.0534
MDL Number:
MFCD06357123
SMILES:
Brc1ccc2c(c1)cc(o2)C(=O)N
Properties
Computed Properties
 
Complexity:
222  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.2  

Downstream Synthesis Route

[1]Locationinpatent:bodytextLee,Jaekyoo;Khanapure,SubhashP.;Kim,Hwa-Ok;Rajur,RajS.B.;Li,Bing;Williams,JohnD.;Pai,Ramdas;Peet,NortonP.[SyntheticCommunications,2010,vol.40,#22,p.3390-3396]

[2]DelPoeta,Maurizio;Schell,WileyA.;Dykstra,ChristineC.;Jones,Susan;Tidwell,RichardR.;Czarny,Agnieszka;Bajic,Miroslav;Bajic,Marina;Kumar,Arvind;Boykin,David;Perfect,JohnR.[AntimicrobialAgentsandChemotherapy,1998,vol.42,#10,p.2495-2502]

[3]Brocos-Mosquera,Iria;Callado,LuisF.;Daelemans,Dirk;DeJonghe,Steven;Djikic,Teodora;Escolano,Carmen;Loza,M.Isabel;Molins,Elies;Nikolic,Katarina;Radan,Milica;Vasilopoulou,Foteini;Bagán,Andrea;Brea,José;García-Fuster,M.Julia;García-Sevilla,JesúsA.;Griñán-Ferré,Christian;Hernández-Hernández,Elena;Martínez,AntónL.;Pérez,Belén;Pallàs,Mercè;Rodriguez-Arévalo,Sergio[EuropeanJournalofMedicinalChemistry,2021,vol.222]

110-85-0   
t-OBu 
  35351-21-4   
1-(N,N-dimethylamino)-1'-(dicyclohexylphosphino)biphenyl 
  7440-44-0    183288-46-2 

[1]Patent:US2003/125558,2003,A1

P(t-Bu)3 
 
t-OBu 
  35351-21-4    57260-71-6    183288-44-0    183288-46-2 

[1]Patent:US2003/125558,2003,A1

P(t-Bu)3 
 
t-OBu 
  2759-28-6    35351-21-4    343306-47-8 

[1]CurrentPatentAssignee:MERCKKGAA-US2003/125558,2003,A1

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:35351-21-4 Molecular Formula|35351-21-4 MDL|35351-21-4 SMILES|35351-21-4 5-Bromo-1-benzofuran-2-carboxamide
Catalog No.: AA00C93K
35351-21-4,MFCD06357123
35351-21-4 | 5-Bromo-1-benzofuran-2-carboxamide
Pack Size: 1g
Purity: 98%
in stock
$99.00 $69.00
Pack Size: 5g
Purity: 98%
in stock
$321.00 $225.00
Pack Size: 10g
Purity: 98%
in stock
$583.00 $408.00
Pack Size: 25g
Purity: 98%
in stock
$1,154.00 $808.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00C93K
Chemical Name: 5-Bromo-1-benzofuran-2-carboxamide
CAS Number: 35351-21-4
Molecular Formula: C9H6BrNO2
Molecular Weight: 240.0534
MDL Number: MFCD06357123
SMILES: Brc1ccc2c(c1)cc(o2)C(=O)N
Properties
Complexity: 222  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 13  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.2  
Downstream Synthesis Route
35351-21-4    35351-45-2 

[1]Locationinpatent:bodytextLee,Jaekyoo;Khanapure,SubhashP.;Kim,Hwa-Ok;Rajur,RajS.B.;Li,Bing;Williams,JohnD.;Pai,Ramdas;Peet,NortonP.[SyntheticCommunications,2010,vol.40,#22,p.3390-3396]

[2]DelPoeta,Maurizio;Schell,WileyA.;Dykstra,ChristineC.;Jones,Susan;Tidwell,RichardR.;Czarny,Agnieszka;Bajic,Miroslav;Bajic,Marina;Kumar,Arvind;Boykin,David;Perfect,JohnR.[AntimicrobialAgentsandChemotherapy,1998,vol.42,#10,p.2495-2502]

[3]Brocos-Mosquera,Iria;Callado,LuisF.;Daelemans,Dirk;DeJonghe,Steven;Djikic,Teodora;Escolano,Carmen;Loza,M.Isabel;Molins,Elies;Nikolic,Katarina;Radan,Milica;Vasilopoulou,Foteini;Bagán,Andrea;Brea,José;García-Fuster,M.Julia;García-Sevilla,JesúsA.;Griñán-Ferré,Christian;Hernández-Hernández,Elena;Martínez,AntónL.;Pérez,Belén;Pallàs,Mercè;Rodriguez-Arévalo,Sergio[EuropeanJournalofMedicinalChemistry,2021,vol.222]

110-85-0   
t-OBu 
  35351-21-4   
1-(N,N-dimethylamino)-1'-(dicyclohexylphosphino)biphenyl 
  7440-44-0    183288-46-2 

[1]Patent:US2003/125558,2003,A1

P(t-Bu)3 
 
t-OBu 
  35351-21-4    57260-71-6    183288-44-0    183288-46-2 

[1]Patent:US2003/125558,2003,A1

P(t-Bu)3 
 
t-OBu 
  2759-28-6    35351-21-4    343306-47-8 

[1]CurrentPatentAssignee:MERCKKGAA-US2003/125558,2003,A1

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Building Blocks More >
352233-14-8
352233-14-8
HydroxyMethyl Tolperisone Hydrochloride
AA00C99V | MFCD19705112
34604-56-3
34604-56-3
3-hydroxy-monoethylglycinexylidide
AA00C9FV | MFCD18379467
41470-05-7
41470-05-7
11-cis-3,4-Didehydro Retinal
AA00C9MS | MFCD30719876
380636-42-0
380636-42-0
rac 6-Methoxycarbonyl-4-phenyl-3,4-dihydrocoumarin
AA00C9TJ | MFCD02853034
377084-05-4
377084-05-4
3-(2,3,4-TRIFLUOROPHENYL)PROPIONIC ACID
AA00C9ZX | MFCD06660214
374726-44-0
374726-44-0
L-Fucose-1-phosphatedisodiumsalt
AA00CAAA | MFCD09750762
40160-26-7
40160-26-7
1-[2-(trifluoromethyl)phenyl]piperazinium chloride
AA00CARP | MFCD22570984
21262-08-8
21262-08-8
N-(4-Bromophenyl)-2-chloropropanamide
AA00CB7Q | MFCD03984459
25700-63-4
25700-63-4
4-[(Thien-2-ylcarbonyl)amino]benzoic acid
AA00CDJ5 | MFCD00587595
218301-24-7
218301-24-7
5-(1,3-Dioxan-2-yl)-1H-indazol-3-amine
AA00CFYW | MFCD20921613
Submit
© 2017 AA BLOCKS, INC. All rights reserved.